ZA983175B - 5, 6, 7-Trisubstituted-4-aminopyrido (2, 3-d) pyrimidine compounds - Google Patents
5, 6, 7-Trisubstituted-4-aminopyrido (2, 3-d) pyrimidine compoundsInfo
- Publication number
- ZA983175B ZA983175B ZA983175A ZA983175A ZA983175B ZA 983175 B ZA983175 B ZA 983175B ZA 983175 A ZA983175 A ZA 983175A ZA 983175 A ZA983175 A ZA 983175A ZA 983175 B ZA983175 B ZA 983175B
- Authority
- ZA
- South Africa
- Prior art keywords
- aminopyrido
- trisubstituted
- pyrimidine compounds
- pyrimidine
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Transplantation (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US84348497A | 1997-04-16 | 1997-04-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA983175B true ZA983175B (en) | 1998-10-21 |
Family
ID=25290123
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA983175A ZA983175B (en) | 1997-04-16 | 1998-04-15 | 5, 6, 7-Trisubstituted-4-aminopyrido (2, 3-d) pyrimidine compounds |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP0975633A1 (xx) |
JP (1) | JP2001520654A (xx) |
KR (1) | KR20010006462A (xx) |
CN (1) | CN1252069A (xx) |
AR (1) | AR012437A1 (xx) |
AU (1) | AU741033B2 (xx) |
BG (1) | BG103853A (xx) |
BR (1) | BR9809056A (xx) |
CA (1) | CA2286592A1 (xx) |
CO (1) | CO4940470A1 (xx) |
HU (1) | HUP0001443A3 (xx) |
IL (1) | IL131617A0 (xx) |
NO (1) | NO995035L (xx) |
NZ (1) | NZ337125A (xx) |
PL (1) | PL336265A1 (xx) |
SK (1) | SK140099A3 (xx) |
TR (1) | TR199902550T2 (xx) |
WO (1) | WO1998046604A1 (xx) |
ZA (1) | ZA983175B (xx) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001057040A1 (en) * | 2000-02-03 | 2001-08-09 | Abbott Laboratories | 6,7-disubstituted-4-aminopyrido[2,3-d]pyrimidine compounds |
HU229604B1 (en) | 2001-02-12 | 2014-02-28 | Hoffmann La Roche | 6-substituted pyrido-pyrimidines, process for their preparation and pharmaceutical compositions containing them |
CN107744520A (zh) * | 2017-10-25 | 2018-03-02 | 南京多宝生物科技有限公司 | 嘧啶类化合物在制备促进小肠蠕动药物中的应用 |
CN112209924B (zh) * | 2019-07-09 | 2022-04-05 | 中国科学院天津工业生物技术研究所 | 选择性腺苷a1受体拮抗剂 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB774094A (en) * | 1953-01-02 | 1957-05-08 | Wellcome Found | Improvements in or relating to pyrimidine compounds |
IL112249A (en) * | 1994-01-25 | 2001-11-25 | Warner Lambert Co | Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds |
-
1998
- 1998-04-13 IL IL13161798A patent/IL131617A0/xx unknown
- 1998-04-13 AU AU71080/98A patent/AU741033B2/en not_active Ceased
- 1998-04-13 EP EP98918091A patent/EP0975633A1/en not_active Withdrawn
- 1998-04-13 CA CA002286592A patent/CA2286592A1/en not_active Abandoned
- 1998-04-13 TR TR1999/02550T patent/TR199902550T2/xx unknown
- 1998-04-13 PL PL98336265A patent/PL336265A1/xx unknown
- 1998-04-13 CN CN98804117A patent/CN1252069A/zh active Pending
- 1998-04-13 WO PCT/US1998/007201 patent/WO1998046604A1/en not_active Application Discontinuation
- 1998-04-13 HU HU0001443A patent/HUP0001443A3/hu unknown
- 1998-04-13 NZ NZ337125A patent/NZ337125A/en unknown
- 1998-04-13 JP JP54408398A patent/JP2001520654A/ja active Pending
- 1998-04-13 BR BR9809056-9A patent/BR9809056A/pt not_active IP Right Cessation
- 1998-04-13 KR KR1019997009552A patent/KR20010006462A/ko not_active Application Discontinuation
- 1998-04-13 SK SK1400-99A patent/SK140099A3/sk unknown
- 1998-04-15 AR ARP980101734A patent/AR012437A1/es unknown
- 1998-04-15 ZA ZA983175A patent/ZA983175B/xx unknown
- 1998-04-16 CO CO98020978A patent/CO4940470A1/es unknown
-
1999
- 1999-10-15 NO NO995035A patent/NO995035L/no not_active Application Discontinuation
- 1999-11-03 BG BG103853A patent/BG103853A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
NO995035D0 (no) | 1999-10-15 |
PL336265A1 (en) | 2000-06-19 |
WO1998046604A1 (en) | 1998-10-22 |
AU7108098A (en) | 1998-11-11 |
CN1252069A (zh) | 2000-05-03 |
KR20010006462A (ko) | 2001-01-26 |
CO4940470A1 (es) | 2000-07-24 |
BG103853A (en) | 2000-06-30 |
HUP0001443A3 (en) | 2001-01-29 |
HUP0001443A2 (hu) | 2000-10-28 |
NO995035L (no) | 1999-12-15 |
IL131617A0 (en) | 2001-01-28 |
NZ337125A (en) | 2001-06-29 |
EP0975633A1 (en) | 2000-02-02 |
BR9809056A (pt) | 2000-08-01 |
AR012437A1 (es) | 2000-10-18 |
JP2001520654A (ja) | 2001-10-30 |
SK140099A3 (en) | 2000-05-16 |
TR199902550T2 (xx) | 2000-04-21 |
CA2286592A1 (en) | 1998-10-22 |
AU741033B2 (en) | 2001-11-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EG23758A (en) | Pyrrolo (2,3-d) pyrimidine compounds | |
IL139586A0 (en) | PYRROLO [2,3-d] PYRIMIDINE COMPOUNDS | |
HK1051195A1 (en) | Pyrrolo(2,3-d)pyrimidine compounds. | |
HK1018439A1 (en) | 5h-thiazolo (3,2-a) pyrimidine derivatives | |
SI1220856T1 (en) | Pyrazolo(4,3-d)pyrimidine derivatives | |
AU1794697A (en) | 7-alkyl-pyrrolo{2,3-d}pyrimidines | |
IL131293A0 (en) | Pyrazine compounds | |
ZA983177B (en) | 5,7-Disubstituted-4-aminopyrdo [2,3] pyrimidine compounds | |
ZA9810920B (en) | Fungicidal combinations comprising theino (2,3-d) pyrimidin-4-one | |
ZA9811725B (en) | Triazine compounds. | |
IL136500A0 (en) | 1,4-diazacycloheptane derivatives | |
IL131892A0 (en) | 6, 7-Disubstituted-4-aminopyrido [2, 3-d] pyrimidine compounds | |
ZA983175B (en) | 5, 6, 7-Trisubstituted-4-aminopyrido (2, 3-d) pyrimidine compounds | |
ZA981529B (en) | Substituted 2,4-diaminopyrimidine | |
AU7073296A (en) | 5,6,7,8-tetrahydropyrido{2,3-d}pyrimidines | |
SI1087970T1 (en) | PYRROLO 2,3-d)PYRIMIDINE COMPOUNDS | |
ZA994004B (en) | Pyrrolo[2,3-d]pyrimidine compounds. | |
SI1210349T1 (en) | PYRAZOLO 4,3-d)PYRIMIDINES | |
IL166937A (en) | Uracil compounds | |
ZA981624B (en) | Pyrazine compounds. |